The Academy of Medical Sciences recently released a report on microbial challenge studies in volunteers.[@bib1] The report is intended as a guidance document for anyone concerned with the appropriateness and conduct of such studies. The main theme of the report is ethical, balancing the rights of volunteers with the needs of the community, and the possible benefits arising from understanding the mechanisms of microbial disease, and how to fight it. The case for undertaking these types of studies is overwhelming, but so are the requirements to get the studies and their aftermath right.

A look at the [panel](#box1){ref-type="boxed-text"} will explain what I mean. Between 1946 and 1989, the Medical Research Council\'s Common Cold Unit (near Salisbury in Wiltshire, UK) did 1006 studies, mostly on 19 911 male and female volunteers (with several thousands volunteering for experiments many times).[@bib2], [@bib3] Thanks to the efforts of the staff and volunteers we know that the cold is a syndrome caused by very many different agents and we have what I call "Tyrrell\'s rule of three". In any given year, a third of upper respiratory infections will have no known cause. A third will be caused by a mixture of agents: this third consists of all known agents, with the exception of rhinoviridae, which cause the remaining third.PanelAchievements of Medical Research Council\'s Common Cold Unit in challenge studies in volunteers 1946--89 (from interviews with the late Dr David Tyrrell in February, 2000)•Defined causes of common cold---mainly in succession of advances in methods of viral isolation, recognition, culture, and successful human-to-human transmission experiments. Towards the end, strong psychological component was recognised.•Described immune responses to common cold---in laboratory assessment of volunteers\' responses.•Produced effective vaccines against common cold and attenuated common cold agents in vaccines---this vaccine activity was less successful, because of multiviral aetiology of common cold. Some vaccines against influenza, rhinovirus, and other agents of common cold were produced.•Assessed effects of natural and synthetic antiviral agents. This assessment activity was done in collaboration with pharmaceutical companies producing compounds.•Assessed effects of environmental interventions (such as local hyperthermia) on prevention or attenuation of common cold.

The understanding of the mechanisms of causality and transmission led to a move away from advocating vaccines for respiratory syndromes, and a renewed interest in any interventions that might enhance general immunity and interrupt transmission. These lessons were partly relearned during the epidemic of severe acute respiratory syndrome but their day-to-day application still escapes humanity.

So, does the report give good guidance on how to gain knowledge and minimise the risk to volunteers intentionally exposed to microbes? Partly, I think. The sections on recruitment and safety of volunteers, the surrounding community, and researchers seem the strongest and most detailed. The recommendations for the creation of a National Expert Advisory Committee to oversee all challenge studies and the institution of a national register are sensible. Researchers will also be grateful for other pointers, such as those about adequate insurance cover. Other crucial parts are, in my view, vague and miss a golden opportunity for moving our knowledge and safeguards further.

The report quotes the Declaration of Helsinki in the development of the rationale for the challenge study: "Medical research involving human subjects must conform to generally accepted scientific principles and should be based on adequately performed laboratory and animal experimentation and on a thorough knowledge of the scientific literature." What is meant by "thorough knowledge" is not specified. The text should contain a specific requirement for quoting or undertaking a systematic review of available human and animal evidence on the topic as an absolute requirement for ethical clearance and funding. This requirement should minimise the risk of the knowledge sought not being already available, and thus volunteers being exposed unnecessarily to microbes when the answer to the study question is already known.

Different study designs are not discussed in the report. Should only comparative designs, such as controlled trials and cohort studies, be included or are non-comparative cohorts acceptable too? This is another ethical conundrum, because controlled trials are the most informative, but cohorts might be needed and the only feasible design in an emergency such as a pandemic.

Next comes the issue of documentation and our responsibilities to future generations. The national register of studies should be expanded to include a confidential depository of all records to do with all challenge studies. Why? Because we do not know what requirements there will be in the future. Historical cohorts of volunteers exposed to microbes and their unexposed controls with their records, tissues (a well-detailed part of the report), and possible follow-up could help answer future questions. Because there are several past and present challenge studies (listed in the report), we should also try our best to obtain as much evidence as possible from these studies and link up internationally similar registers. The idea is to squeeze every drop of evidence from existing animal and human studies.

What about the role of the pharmaceutical industry in challenge studies? It is odd that no mention is made of their role, as the review group was chaired by an industry physician and, in the Common Cold Unit\'s days, industry provided most of the experimental antiviral compounds for testing, while contributing to vaccine production and testing.

The report is good and its publication timely, but its content is too general and in parts is outdated.

Challenge studies are difficult but vital, let us not lose this opportunity for advancing our understanding, and making sure no-one is exposed to microbes unnecessarily.

I dedicate this Comment to the memory of Dr David Tyrrell. I declare that I make an income from doing systematic reviews.
